Publication | Open Access
Serum microRNA-221 as a biomarker for diabetic retinopathy in patients associated with type 2 diabetes
45
Citations
13
References
2018
Year
Serum miR-221 as a potential biomarker could be related to not only occurrence but also progression for DR in patients with T2D. However, a prospective clinical trial is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1